Zonguldak Bülent Ecevit University Hospital
Zonguldak, Zonguldak Province, Turkey (Türkiye)
NCT Number: NCT07487415
Aim: In this study, we primarily aimed to determine the effect of anterior Quadratus Lumborum Block (QLB) on intraoperative and postoperative opioid consumption in patients undergoing percutaneous nephrolithotomy (PCNL) surgery under general anesthesia. Secondarily, we aimed to evaluate opioid-related complications and investigate the impact of anterior QLB on the quality of postoperative recovery using the QoR-15 (Quality of Recovery-15) questionnaire.
Materials and Methods: The study included 60 patients aged 18-75, with ASA physical status I-III, who were scheduled for elective PCNL. Patients were randomly assigned to either the Control Group (n=30) or the Anterior QLB Group (n=30). Following dropouts during follow-up, a total of 54 patients (27 in each group) were analyzed. Preoperative block was performed in the Anterior QLB group. In both groups, following anesthesia induction, anesthesia maintenance was provided with sevoflurane to maintain a BIS value of 40-60, and the remifentanil dosage was adjusted to keep the ANI between 50-70. Operation time, surgical duration, extubation time, intraoperative hemodynamic data, ANI values, and the amount of intraoperative remifentanil consumed were recorded. Postoperative recovery unit pain scores, incidence of nausea and vomiting, and additional analgesic requirements were documented. Pain scores at the 1st, 2nd, 6th, 12th, and 24th postoperative hours, postoperative complications (nausea, vomiting, etc.), opioid consumption, and the results of the QoR-15 questionnaire at the 24th hour were recorded.
Results: Intraoperative remifentanil consumption, both in terms of total dose and weight-adjusted infusion rate, was significantly lower in the Anterior QLB group (p<0.001). Pain scores were significantly lower in the Anterior QLB group both in the recovery unit and at all postoperative time points (p<0.05). Postoperative cumulative tramadol consumption was also lower in the Anterior QLB group across all time intervals (p<0.05). No significant difference was found between the two groups regarding the incidence of postoperative nausea and vomiting. Furthermore, no significant difference was observed in the QoR-15 questionnaire scores evaluated at the 24th postoperative hour.
Conclusion: Anterior QLB is an effective analgesic method in percutaneous nephrolithotomy surgery, reducing perioperative opioid consumption and postoperative pain scores. It is concluded that anterior QLB is effective as a significant component of the multimodal analgesia strategy by preventing potential side effects associated with opioid consumption.
Looking for future studies?
Notify Me18 year–75 year
All sexes
Interventional
Not applicable
Zonguldak, Zonguldak Province, Turkey (Türkiye)
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
injection local anesthetic between quadratus lumborum and psaos major
Time frame: first 24 hours after surgery
primary aimed to determine the effect of anterior Quadratus Lumborum Block (QLB) on intraoperative and postoperative opioid consumption in patients undergoing percutaneous nephrolithotomy (PCNL) surgery under general anesthesia.
Time frame: postoperative 24th hour
Time frame: postoperative 0, 1, 2, 6, 12, 24 th hour
Zonguldak Bulent Ecevit University
Other
Perioperative Analgesia Management in Patients Undergoing Percutaneous Nephrolithotomy Following Anterior Quadratus Lumborum Block
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07457983
Calculi, Female Urogenital Diseases
Adıyaman, Turkey (Türkiye)
View Trial DetailsNCT06957301
Percutaneous Nephrolithotomy (PCNL)
Alexandria, Alexandria Governorate, Egypt
View Trial DetailsNCT07471711
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Guangzhou, Guangdong / 广东, China
View Trial DetailsNCT07279389
Percutaneous Nephrolithotomy (PCNL), Renal Stone Disease
Cairo, Cairo Governorate, Egypt
View Trial Details